Amanda Anisimova Ends 2026 Season Early Due to Recurring
Amanda Anisimova has ended her 2026 season early, citing a recurring wrist injury as the reason for her withdrawal from the final tournaments of the year. The American star confirmed the decision in a social media post on Monday, October 2, 2026, stating she needed to address the physical problem that has plagued her campaign.
A Major Ranking Blow Follows Her Withdrawal
Anisimova's early finish comes with an immediate and significant ranking penalty. She was forced to pull out of the WTA 1000 China Open in Beijing, where she was the defending champion. By not playing, she will lose the full 1,000 ranking points she earned by winning the title in 2025. Her total is projected to fall from 3,363 points to 2,363, dropping her from the world's top 15 to around World No. 16. This setback also damages her late push for a spot in the season-ending WTA Finals in Riyadh.
The 2026 season never matched the heights of Anisimova's breakthrough 2025, where she reached two Grand Slam finals and won two WTA 1000 titles. She started solidly with an Australian Open quarter-final run, losing to compatriot Jessica Pegula. A semi-final at Indian Wells in March was a high point, but illness forced a retirement in Doha and she struggled on grass. Her final match was a round of 16 exit at the Canadian Open in August, followed by withdrawals in Cincinnati and Singapore before the season was called.
| Tournament | Result | Key Detail |
|---|---|---|
| Australian Open | Quarter-finals | Lost to Jessica Pegula |
| Indian Wells | Semi-finals | High point of season |
| Roland Garros | Third Round | Exited in Paris |
| Wimbledon | Third Round | Lost to Madison Keys |
| China Open | Withdrew | Defending champion, lost 1,000 points |
Anisimova Claps Back at Body and Ozempic Speculation
Off the court, Anisimova has faced persistent and unwelcome scrutiny about her physique. After recent social media posts led to fan speculation she was using the weight-loss medication Ozempic, she issued a firm denial on her Instagram story. "To all the health experts and professional body commentators in the comments: I'm not taking Ozempic," Anisimova said. "Please leave me alone and out of your posts." This is not a new battle for the 25-year-old, who has previously responded to body-shaming comments and took a mental health break from tennis in early 2023 partly due to such pressures.
Anisimova's current challenges place her in a complex spot within the American tennis landscape. While Coco Gauff has solidified her status as a multi-time Grand Slam champion and teenager Iva Jovic is rising fast, Anisimova's path has been interrupted. Once a teenage prodigy who reached the 2022 Roland Garros semi-final, her career has been a story of immense potential meeting repeated physical and mental hurdles. Her ranking slide and injury pause make her immediate trajectory harder to forecast than her peers.
- Season Ended: Anisimova confirmed her 2026 season is over on October 2 due to a wrist injury.
- Ranking Fall: She will drop out of the WTA Top 15, losing 1,000 points by missing the China Open.
- Public Pushback: The athlete directly denied using Ozempic and told online critics to leave her alone.
Her focus now shifts entirely to recovery. Anisimova will need a healthy off-season to reset and rebuild for 2027, aiming to recapture the form that made her a champion in Beijing just a year ago. Fans can track her return and the latest WTA standings on our [standings](/standings) page.